In another two RNA-seq datasets for advanced non-small cell lung cancer (NSCLC) patients who were treated with immunotherapy ± chemotherapy (GSE135222 and Orient-11), a high PPARG score was associated with a better prognosis (Fig. 4J–K). This evidence concerns the gene PPARG and non-small cell lung carcinoma.